Shares of Health Care sector company Teva Pharmaceutical Industries moved -6.3% today, and are now trading at a price of $8.82. The large-cap stock's daily volume was 12,456,602 compared to its average volume of 9,278,993. The S&P 500 index returned a 1.0% performance.
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, Israel, and internationally. The company is based in Tel Aviv and has 34,004 full time employees. Its market capitalization is $9,891,677,184.
9 analysts are following Teva Pharmaceutical Industries and have set target prices ranging from $8.0 to $14.0 per share. On average, they have given the company a rating of hold. At today's prices, TEVA is trading -16.43% away from its average analyst target price of $10.56 per share.
Over the last year, TEVA's share price has increased by 11.0%, which represents a difference of -10.0% when compared to the S&P 500. The stock's 52 week high is $11.45 per share whereas its 52 week low is $7.09.
Date Reported | Cash Flow from Operations ($ k) | Capital expenditures ($ k) | Free Cash Flow ($ k) | YoY Growth (%) |
---|---|---|---|---|
2023-02-10 | 1,590,000 | -480,000 | 2,070,000 | 97.33 |
2022-02-09 | 798,000 | -251,000 | 1,049,000 | -39.26 |
2021-02-10 | 1,216,000 | -511,000 | 1,727,000 | 85.7 |
2020-02-21 | 748,000 | -182,000 | 930,000 | -31.72 |
2019-02-19 | 2,446,000 | 1,084,000 | 1,362,000 | -56.05 |
2018-02-01 | 2,225,000 | -874,000 | 3,099,000 |